The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Abstract
FBW7 (F-box and WD repeat domain-containing 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase. SCF(FBW7) degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN. FBW7 is also a tumour suppressor, the regulatory network of which is perturbed in many human malignancies. Numerous cancer-associated mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis. This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FBXW7 ubiquitin ligase is a component of the SCF complex and mediates degradation of several cell cycle proteins,158 and its β-isoform is induced by p53.159”
From Census and evaluation of p53 target genes (2017) · cites this paper as [158]
Citations
Cites
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Many mitogens induce JUN activity, and JUN functions as part of the AP1 transcription factor to exert its positive effect on cell proliferatio”
BackgroundActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Genetic Control of the Cell Division Cycle in Yeast
Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,450
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M. G., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,421
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Global signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,144
Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis
Yang, Y., Gao, X., Zhang, M., Yan, S., Sun, C., Xiao, F., Huang, N., Yang, X., Zhao, K., Zhou, H., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx166 · Cited by 1,114
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Snaebjornsson, M. T., Janaki-Raman, S., & Schulze, A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.010 · Cited by 1,097
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2396 · Cited by 903
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Wertz, I. E., Kusam, S., Lam, C., Okamoto, T., Sandoval, W. N., Anderson, D. J., Helgason, E., Ernst, J. A., Eby, M., Liu, J., et al. (2011) · Nature · doi:10.1038/nature09779 · Cited by 801
Mechanisms and function of substrate recruitment by F-box proteins
Skaar, J. R., Pagan, J. K., & Pagano, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3582 · Cited by 671
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutiérrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 635
Sarikas, A., Hartmann, T., & Pan, Z. (2011) · Genome biology · doi:10.1186/gb-2011-12-4-220 · Cited by 541
Roles of F-box proteins in cancer
Wang, Z. P., Liu, P., Inuzuka, H., & Wei, W. (2014) · Nature reviews. Cancer · doi:10.1038/nrc3700 · Cited by 522
FBXW7: a critical tumor suppressor of human cancers
Yeh, C., Bellon, M., & Nicot, C. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0857-2 · Cited by 525
Zhu, S., Chen, W., Masson, A., & Li, Y. (2024) · Cell Discovery · doi:10.1038/s41421-024-00689-6 · Cited by 538
Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V. B., Sharpe, H. J., McKee, T., Letourneau, A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3525 · Cited by 491
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Vucic, D., Dixit, V. M., & Wertz, I. E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3143 · Cited by 468
Keersmaecker, K. D., Atak, Z. K., Li, N., Vicente, C., Patchett, S., Girardi, T., Gianfelici, V., Geerdens, E., Clappier, E., Porcu, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2508 · Cited by 445
FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression
Mao, J., Kim, I.-J., Wu, D., Climent, J., Kang, H. C., Delrosario, R., & Balmain, A. (2008) · Science · doi:10.1126/science.1162981 · Cited by 434
Gallo, M. L., O’Hara, A. J., Rudd, M. L., Urick, M. E., Hansen, N. F., O’Neil, N. J., Price, J. C., Zhang, S., England, B. M., Godwin, A. K., et al. (2012) · Nature Genetics · doi:10.1038/ng.2455 · Cited by 426
Lipkowitz, S., & Weissman, A. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3120 · Cited by 422
Role of metabolism in cancer cell radioresistance and radiosensitization methods
Tang, L. M., Wei, F., Wu, Y., He, Y., Shi, L., Xiong, F., Gong, Z., Guo, C. J., Li, X., Deng, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0758-7 · Cited by 426
An Overview of MYC and Its Interactome
Conacci-Sorrell, M., McFerrin, L., & Eisenman, R. N. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014357 · Cited by 408
Signaling Pathways that Control Cell ProliferationPreprint
Duronio, R. J., & Xiong, Y. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008904 · Cited by 395
The Mediator complex and transcription regulation
Poss, Z. C., Ebmeier, C. C., & Taatjes, D. J. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.840259 · Cited by 364
Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth
Edgar, B. A., Zielke, N., & Gutiérrez, C. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3756 · Cited by 360
Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities
Davis, R. J., Welcker, M., & Clurman, B. E. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.013 · Cited by 343
Self-citationUbiquitin signaling in cell cycle control and tumorigenesis
Dang, F., Nie, L., & Wei, W. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00648-0 · Cited by 353
SCF ubiquitin ligase-targeted therapies
Skaar, J. R., Pagan, J. K., & Pagano, M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4432 · Cited by 344
Building and remodelling Cullin–RING E3 ubiquitin ligases
Lydeard, J. R., Schulman, B. A., & Harper, J. W. (2013) · The EMBO Reports · doi:10.1038/embor.2013.173 · Cited by 327
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma
Zhao, S., Choi, M., Overton, J. D., Bellone, S., Roque, D. M., Cocco, E., Guzzo, F., English, D. P.-G., Varughese, J., Gasparrini, S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222577110 · Cited by 323
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
Dotto, G. P., & Rustgi, A. K. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.04.004 · Cited by 329
The First Approved Gene Therapy Product for Cancer Ad- p53 (Gendicine): 12 Years in the Clinic
Zhang, W., Li, L., Li, D., Liu, J., Li, X., Li, W., Xu, X., Zhang, M. J., Chandler, L. A., Lin, H., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.218 · Cited by 334
Huang, K. K., Ramnarayanan, K., Zhu, F., Srivastava, S., Xu, C., Tan, A. L. K., Lee, M., Tay, S. T., Das, K., Xing, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.11.018 · Cited by 303
Cullin-RING Ligases as Attractive Anti-cancer Targets
Zhao, Y., & Sun, Y. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990300 · Cited by 279
Ubiquitination: Friend and foe in cancer
Mansour, M. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.06.001 · Cited by 280
FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
Zeng, Y., Zhuo, Q., Hu, Q., Xu, X., Liu, M., Zhang, Z., Xu, W., Liu, W., Fan, G., Qin, Y., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101807 · Cited by 271
Zhao, Y., Xiong, X., & Sun, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.029 · Cited by 273
Zhang, G., Li, S., Lu, J., Ge, Y., Wang, Q., Ma, G., Zhao, Q., Wu, D., Gong, W., Du, M., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0829-6 · Cited by 270
Ubiquitination and the Regulation of Membrane Proteins
Foot, N. J., Henshall, T. L., & Kumar, S. (2016) · Physiological Reviews · doi:10.1152/physrev.00012.2016 · Cited by 272
Protein damage, repair and proteolysis
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 271
Ubiquitin Ligases and Cell Cycle Control
Teixeira, L. K., & Reed, S. I. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060410-105307 · Cited by 262
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Kuhn, E., Wu, R., Guan, B., Wu, G., Zhang, J., Wang, Y., Song, L., Yuan, X., Wei, L., Roden, R. B. S., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs345 · Cited by 249
Emerging role of lipid metabolism alterations in Cancer stem cells
Yi, M., Li, J., Chen, S., Cai, J., Ban, Y., Peng, Q., Zhou, Y., Zeng, Z., Peng, S., Li, X., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0784-5 · Cited by 253
CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition
Gallo, D., Young, J. T. F., Fourtounis, J., Martino, G., Álvarez-Quilón, A., Bernier, C., Duffy, N. M., Papp, R., Roulston, A., Stocco, R., et al. (2022) · Nature · doi:10.1038/s41586-022-04638-9 · Cited by 246
Emerging roles of Myc in stem cell biology and novel tumor therapies
Yoshida, G. J. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0835-y · Cited by 252
An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
Ceccarelli, D. F. J., Tang, X., Pelletier, B., Orlicky, S. M., Xie, W., Plantevin, V., Neculai, D., Chou, Y.-C., Ogunjimi, A. A., Al-Hakim, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.039 · Cited by 241
Li, Y., Xie, P., Lu, L., Wang, J., Diao, L., Liu, Z., Guo, F., He, Y., Liu, Y., Huang, Q., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00299-9 · Cited by 234
Chen, T.-C., Chuang, J., Ko, C., Kao, T., Yang, P.-Y., Yu, C.-H., Liu, M.-S., Hu, S.-L., Tsai, Y.-T., Chan, H., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101413 · Cited by 230
Structural assembly of cullin-RING ubiquitin ligase complexes
Zimmerman, E. S., Schulman, B. A., & Zheng, N. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.08.010 · Cited by 227
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy
Soucy, T. A., Dick, L. R., Smith, P. G., Milhollen, M. A., & Brownell, J. E. (2010) · Genes & Cancer · doi:10.1177/1947601910382898 · Cited by 225
The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc
Sun, X., He, X., Yin, L., Komada, M., Sears, R. C., & Dai, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411713112 · Cited by 220
Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size
Acebrón, S. P., Karaulanov, E., Berger, B. S., Huang, Y., & Niehrs, C. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.014 · Cited by 228
LSD1: more than demethylation of histone lysine residues
Perillo, B., Tramontano, A., Pezone, A., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00542-2 · Cited by 225
Therapeutic strategies targeting cancer stem cells
Yoshida, G. J., & Saya, H. (2015) · Cancer Science · doi:10.1111/cas.12817 · Cited by 222
Gan, W., Dai, X., Lunardi, A., Li, Z., Inuzuka, H., Liu, P., Varmeh, S., Zhang, J., Liang Cheng, C., Sun, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.026 · Cited by 220
Willis, M. S., Townley-Tilson, W. H. D., Kang, E., Homeister, J. W., & Patterson, C. (2010) · Circulation Research · doi:10.1161/circresaha.109.208801 · Cited by 214
MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 223
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
Zender, S., Nickeleit, I., Wüestefeld, T., Sörensen, I., Dauch, D., Bozko, P. M., El-Khatib, M., Geffers, R., Bektas, H., Manns, M. P., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.04.019 · Cited by 204
Xiao, L., Hu, Z., Dong, X., Tan, Z. W., Li, W., Tang, M., Chen, L., Yang, L., Tao, Y., Jiang, Y., et al. (2014) · Oncogene · doi:10.1038/onc.2014.32 · Cited by 197
CRY2 and FBXL3 Cooperatively Degrade c-MYC
Huber, A., Papp, S. J., Chan, A. B., Henriksson, E., Jordan, S. D., Kriebs, A., Nguyen, M., Wallace, M., Li, Z., Metallo, C. M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.012 · Cited by 203
Xiong, Z., Xu, K., Lin, Z., Kong, F., Wang, Q., Quan, Y., Sha, Q., Li, F., Zou, Z., Liu, L., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00928-6 · Cited by 199
Flügel, D., Görlach, A., & Kietzmann, T. (2011) · Blood · doi:10.1182/blood-2011-08-375014 · Cited by 190
GSK-3 – at the crossroads of cell death and survival
Maurer, U., Preiss, F., Brauns‐Schubert, P., Schlicher, L., & Charvet, C. (2014) · Journal of Cell Science · doi:10.1242/jcs.138057 · Cited by 193
Cell-fate determination by ubiquitin-dependent regulation of translation
Werner, A., Iwasaki, S., McGourty, C. A., Medina-Ruiz, S., Teerikorpi, N., Fedrigo, I., Ingolia, N. T., & Rape, M. (2015) · Nature · doi:10.1038/nature14978 · Cited by 184
Hales, E. C., Taub, J. W., & Matherly, L. H. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.021 · Cited by 187
NEDD8 Pathways in Cancer, Sine Quibus Non
Watson, I. R., Irwin, M. S., & Ohh, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.002 · Cited by 189
Tu, K., Yang, W., Li, C. R., Zheng, X. M., Lu, Z., Guo, C., Yao, Y., & Liu, Q. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-110 · Cited by 183
Functions of Notch Signaling in the Immune System: Consensus and Controversies
Yuan, J. S., Kousis, P. C., Suliman, S., Visan, I., & Guidos, C. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132719 · Cited by 180
Role of Ubiquitin Ligases and the Proteasome in Oncogenesis: Novel Targets for Anticancer Therapies
Micel, L. N., Tentler, J. J., Smith, P. G., & Eckhardt, G. S. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.0958 · Cited by 178
Xiao, D., Yue, M., Su, H., Ren, P., Jiang, J., Li, F., Hu, Y., Du, H., Liu, H., & Qing, G. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.09.016 · Cited by 174
Li, C., Ao, J., Fu, J., Lee, D.-F., Xu, J., Lonard, D. M., & O’Malley, B. W. (2011) · Oncogene · doi:10.1038/onc.2011.151 · Cited by 173
Heßmann, E., Schneider, G., Ellenrieder, V., & Siveke, J. T. (2015) · Oncogene · doi:10.1038/onc.2015.216 · Cited by 178
Babaei‐Jadidi, R., Li, N., Saadeddin, A., Spencer‐Dene, B., Jandke, A., Muhammad, B. A., Ibrahim, E. E., Muraleedharan, R., Abuzinadah, M. F., Belnoue-Davis, H. L., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100830 · Cited by 175
Niu, Z., Jin, R., Zhang, Y., & Li, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01200-x · Cited by 185
Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7
Thompson, B. J., Janković, V., Gao, J., Buonamici, S., Vest, A., Lee, J. M., Zavadil, J., Nimer, S. D., & Aifantis, I. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080277 · Cited by 171
The importance of regulatory ubiquitination in cancer and metastasis
Gallo, L. H., Ko, J., & Donoghue, D. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288326 · Cited by 172
Maya‐Mendoza, A., Ostráková, J., Košař, M., Hall, A., Dušková, P., Mistrík, M., Merchut‐Maya, J. M., Hodný, Z., Bártková, J., Christensen, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 179
Kwun, H. J., Shuda, M., Feng, H., Camacho, C. J., Moore, P. S., & Chang, Y. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.008 · Cited by 180
An integrated view of cyclin E function and regulation
Siu, K. T., Rosner, M. R., & Minella, A. C. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18775 · Cited by 177
USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer
Pan, J., Deng, Q., Jiang, C., Wang, X., Niu, T., Li, H., Chen, T., Jin, J., Pan, W., Cai, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.327 · Cited by 169
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 183
Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun
Hoeck, J. D., Jandke, A., Blake, S. M., Nye, E. L., Spencer‐Dene, B., Brandner, S., & Behrens, A. (2010) · Nature Neuroscience · doi:10.1038/nn.2644 · Cited by 170
Jones, S., Stransky, N., McCord, C. L., Cerami, E. G., Lagowski, J. P., Kelly, D. D., Angiuoli, S. V., Sausen, M., Kann, L. M., Shukla, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6006 · Cited by 169
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Sailo, B. L., Banik, K., Girisa, S., Bordoloi, D., Fan, L., Halim, C. E., Wang, H., Kumar, A. P., Zheng, D., Mao, X., et al. (2019) · Cancers · doi:10.3390/cancers11020246 · Cited by 168
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Busino, L., Millman, S. E., Scotto, L., Kyratsous, C. A., Basrur, V., O’Connor, O. A., Hoffmann, A., Elenitoba‐Johnson, K. S. J., & Pagano, M. (2012) · Nature Cell Biology · doi:10.1038/ncb2463 · Cited by 165
Mechanisms, Hallmarks, and Implications of Stem Cell Quiescence
Cho, I., Lui, P. P., Obajdin, J., Riccio, F., Stroukov, W., Willis, T. L., Spagnoli, F. M., & Watt, F. M. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.05.012 · Cited by 171
Key signalling nodes in mammary gland development and cancer: Myc
Hynes, N. E., & Stoelzle, T. (2009) · Breast Cancer Research · doi:10.1186/bcr2406 · Cited by 159
Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBα Degradation
Zhao, X., Hirota, T., Han, X., Cho, H., Chong, L.-W., Lamia, K. A., Liu, S., Atkins, A. R., Banayo, E., Liddle, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.012 · Cited by 162
Regulation of the mammalian heat shock factor 1
Naidu, S. D., & Dinkova‐Kostova, A. T. (2017) · FEBS Journal · doi:10.1111/febs.13999 · Cited by 174
p53 -Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
Yokobori, T., Mimori, K., Iwatsuki, M., Ishii, H., Onoyama, I., Fukagawa, T., Kuwano, H., Nakayama, K. I., & Mori, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2846 · Cited by 159
Skp2 in the ubiquitin‐proteasome system: A comprehensive review
Asmamaw, M. D., Liu, Y., Zheng, Y., Shi, X., & Liu, H. (2020) · Medicinal Research Reviews · doi:10.1002/med.21675 · Cited by 161
Regulation of gene transcription by the oncoprotein MYC
Lüscher, B., & Vervoorts, J. (2011) · Gene · doi:10.1016/j.gene.2011.12.027 · Cited by 162
Cyclin C is a haploinsufficient tumour suppressor
Li, N., Fassl, A., Chick, J. M., Inuzuka, H., Li, X., Mansour, M. R., Liu, L., Wang, H., King, B., Shaik, S., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3046 · Cited by 157
Notch Targets and Their Regulation
Bray, S. J., & Bernard, F. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92008-5 · Cited by 160
Small-molecule inhibitors of the Myc oncoprotein
Fletcher, S., & Prochownik, E. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.005 · Cited by 160
Tumor suppressor functions of FBW7 in cancer development and progression
Wang, Z. P., Inuzuka, H., Zhong, J., Wan, L., Fukushima, H., Sarkar, F. H., & Wei, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.017 · Cited by 154
Fu, L., Kim, Y.-A., Wang, X., Wu, X., Yue, P., Lonial, S., Khuri, F. R., & Sun, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2190 · Cited by 153
Control of cell growth by the SCF and APC/C ubiquitin ligases
Skaar, J. R., & Pagano, M. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.08.004 · Cited by 159
Metadata
- Authors
- Welcker, M., & Clurman, B. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Welcker, Markus
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 83-93
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2142183096
- Cited by
- 1,084
- References
- 120
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 34 · 2023: 38 · 2022: 53 · 2021: 67 · 2020: 64 · 2019: 69 · 2018: 67 · 2017: 68 · 2016: 74 · 2015: 77 · 2014: 73 · 2013: 82 · 2012: 76
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL084205)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- FBXW7, SCF ubiquitin ligase, tumour suppressor, MYC degradation, cyclin E, notches, c-Jun, chromosomal instability, carcinogenesis, cancer-associated mutations, cell division, cell growth, cell differentiation
- MeSH terms
- F-Box-WD Repeat-Containing Protein 7, Animals, Cell Differentiation, Cell Division, Humans, Models, Biological, Mutation, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Cycle Proteins, Dimerization, Cyclin E, Ubiquitin-Protein Ligases, F-Box Proteins, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review